・Earlier this year, Culper Research alleged channel stuffing and undisclosed related-party transactions at Adma. ・Adma said on Wednesday that there is no evidence of any illegal activity at the ...
ADMA Biologics (ADMA) declined more than 17% on Thursday after the company lowered its full-year outlook and withdrew its long-term guidance, citing “uncertainty in the competitive landscape”. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results